Merck (MRK) Assets Average (2009 - 2026)

Merck (MRK) has 18 years of Assets Average data on file, last reported at $132.8 billion in Q1 2026.

• Assets Average for Q1 2026 came in at $132.8 billion, up 14.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $132.8 billion (up 14.35% YoY), and the FY2025 annual result was $127.0 billion, up 13.49% from the prior year.
• Assets Average steadied at $132.8 billion in Q1 2026 per MRK's latest filing, from $133.2 billion in the prior quarter.
• Over five years, Assets Average peaked at $133.2 billion in Q4 2025 and troughed at $105.6 billion in Q3 2023.
• A 5-year average of $113.2 billion and a median of $108.5 billion in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2024: Assets Average gained 17.75% in 2022, then decreased 2.04% in 2024.
• A 5-year view of Assets Average shows it stood at $108.1 billion in 2022, then slipped by 1.31% to $106.7 billion in 2023, then gained by 9.95% to $117.3 billion in 2024, then climbed by 13.54% to $133.2 billion in 2025, then declined by 0.32% to $132.8 billion in 2026.
• Business Quant data shows MRK's Assets Average at $132.8 billion in Q1 2026, $133.2 billion in Q4 2025, and $123.5 billion in Q3 2025.